Dorma Kaba Holding AG (DOKA)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 66.20 |
|---|---|
| 52-week range | 47.15 – 71.70 |
| Return, 1 month / 3 months | +4.6% / +17.2% |
| Return, 1 year / 3 years | −3.3% / +67.0% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 28.7% |
| Worst drawdown (1 year) | -31.0% |
| Average daily value traded | 3.45M CHF |
| Dividend yield | 13.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dorma Kaba Holding AG is a Swiss company that makes door hardware and access control products. Its range includes door closers, hinges, locks, automatic door systems and electronic access control equipment. The company supplies building contractors, architects, facility managers and security installers, and it serves commercial, public and residential building projects in many countries. It is based in Switzerland and operates internationally through its door hardware and access solutions businesses.
On this site Dorma Kaba Holding AG appears as a stock on the SIX Swiss Exchange (Switzerland), code DOKA, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dorma Kaba Holding AG (DOKA) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 66.20 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 67 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.3% and over the last three months it rose 17.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.0% | ||
| From 52-week high | -5.3% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.2% | ||
| 6-month return | 23.7% | ||
| 12-month return, skipping the last month | -7.6% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.0% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.45M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 13.9% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +4.6% |
| 3 months | +17.2% |
| 6 months | +23.7% |
| 1 year | −3.3% |
| 3 years | +67.0% |
| 5 years | +3.3% |
Signals
| 50-day / 200-day average | 62.25 / 57.09 |
|---|---|
| Golden / death cross (60 days) | Golden, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Oct 2025 | CHF 9.2000 |
| 14 Oct 2024 | CHF 0.3600 |
| 9 Oct 2023 | CHF 4.7500 |
| 13 Oct 2022 | CHF 5.7500 |
| 14 Oct 2021 | CHF 6.2500 |
| 22 Oct 2020 | CHF 5.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.